tradingkey.logo

LENSAR Inc

LNSR
12.080USD
-0.200-1.63%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
144.17MCap. mercado
PérdidaP/E TTM

Más Datos de LENSAR Inc Compañía

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

Información de LENSAR Inc

Símbolo de cotizaciónLNSR
Nombre de la empresaLENSAR Inc
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoCurtis (Nicholas T)
Número de empleados140
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 21
Dirección2800 Discovery Drive
CiudadORLANDO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32826
Teléfono18885367271
Sitio Webhttps://www.lensar.com/
Símbolo de cotizaciónLNSR
Fecha de salida a bolsaSep 21, 2020
Director ejecutivoCurtis (Nicholas T)

Ejecutivos de LENSAR Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-7374.00%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-7374.00%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7374.00%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-7374.00%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
792.29K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
543.27K
-7374.00%
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
239.04K
-7374.00%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
85.57K
-7374.00%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
80.84K
-7374.00%
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
8.67M
67.96%
Europe
2.31M
18.12%
Asia (excluding South Korea)
1.55M
12.17%
South Korea
183.00K
1.43%
Other
41.00K
0.32%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 15 de ago
Actualizado: vie., 15 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
6.51%
BlackRock Institutional Trust Company, N.A.
4.82%
Link (William J)
4.55%
Otro
68.27%
Accionistas
Accionistas
Proporción
North Run Capital, LP
9.21%
Curtis (Nicholas T)
6.63%
Brandes Investment Partners, L.P.
6.51%
BlackRock Institutional Trust Company, N.A.
4.82%
Link (William J)
4.55%
Otro
68.27%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
25.35%
Individual Investor
19.34%
Hedge Fund
13.94%
Investment Advisor/Hedge Fund
7.48%
Pension Fund
1.42%
Bank and Trust
1.15%
Research Firm
0.65%
Otro
30.67%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
162
5.97M
49.99%
-603.16K
2025Q3
148
5.64M
47.18%
-98.25K
2025Q2
124
7.77M
65.87%
+342.80K
2025Q1
115
7.48M
63.69%
+236.19K
2024Q4
93
7.07M
60.29%
-575.26K
2024Q3
87
7.23M
62.19%
-377.24K
2024Q2
90
7.17M
61.87%
-380.16K
2024Q1
87
6.85M
59.77%
-601.54K
2023Q4
89
6.81M
60.46%
-688.43K
2023Q3
96
7.03M
62.74%
-797.20K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
North Run Capital, LP
1.10M
9.21%
--
--
Mar 23, 2025
Curtis (Nicholas T)
792.29K
6.63%
--
--
Oct 24, 2025
Brandes Investment Partners, L.P.
777.70K
6.51%
+214.12K
+37.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
575.55K
4.82%
+40.67K
+7.60%
Sep 30, 2025
Link (William J)
543.27K
4.55%
-7.37K
-1.34%
Oct 24, 2025
The Vanguard Group, Inc.
507.60K
4.25%
+1.45K
+0.29%
Sep 30, 2025
Connaughton (Alan B.)
279.22K
2.34%
--
--
Oct 24, 2025
Lindstrom (Richard L)
239.04K
2%
-7.37K
-2.99%
Oct 24, 2025
Dimensional Fund Advisors, L.P.
224.93K
1.88%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
217.89K
1.82%
-1.49K
-0.68%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Ver más
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
iShares Micro-Cap ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
Global X Russell 2000 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI